|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||||
| Cash & cash equivalents | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Promissory note due to related party - note 5 and 6 | ||||||||||||||||||||
| Demand loan payable due to related party - note 5 and 7 | ||||||||||||||||||||
| Demand loan payable due to related party - note 5 and 7A3 | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Long-term Liabilities | ||||||||||||||||||||
| Promissory note due to related party - note 5 and 6 | ||||||||||||||||||||
| Convertible note - note 8 | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common stock, ($0.0001 par value, 100,000,000 shares authorized 9,948,330 as of Jun 30, 2026 and Dec 31, 2025 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| TOTAL LIABILITIES & STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
